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contagious viruses known to humans, primarily causing
an acute disease (Katz, 1985; Griffin, 2001), with attack
rates in virgin populations 90% (Katz, 1985; Griffin,
2001; Oldstone, 1998). After an incubation period of ap-
proximately 11 days, clinical manifestations character-
ized by fever, coryza, cough, conjunctivitis, exanthema-
tous rash, photophobia, and headache occur. These clin-
ical findings complemented by laboratory studies point
to involvement of the nasal–respiratory mucosal tract,
lymphoid organs, alimentary tract, and central nervous
system (CNS) during this infection.
Observations in humans and nonhuman primates in-
dicate that during the first 2 days of the incubation
period, MV replicates in nasal, tracheal, bronchial, and
pulmonary epithelial cells (Katz, 1985; Griffin, 2001; Mc-
Chesney et al., 1997; Sakaguchi et al., 1986). Later virus
can be isolated from nasal and throat washings. Virus is
believed to be transmitted from the respiratory tract to
local lymphoid tissues but, as suggested in the accom-
panying minireview by Yanagi et al. (2002), may possibly
initially infect activated lymphoid cells, although there is
as yet no direct evidence for this assumption. Neverthe-
less, MV was first isolated from buffy-coat lymphoid cells
(Peebles, 1967) in the blood and is easily obtained from
lymphoid cells during the course of infection.
Replication in lymphoid tissues in vivo gives rise to
syncytia or reticuloendothelial giant cells (Warthin–
Finkeldey cells). Dendritic cells (DC) resident in mucosal
tissues play an important role in local immune surveil-
lance against invading pathogens. DC in the respiratory
tract are located within the upper layers of epithelial cells
and extend their dendritic processes toward the luminal
side of tissues; these DC are important for the uptake of
virus penetrating through surface epithelial and for trans-
porting that material for presentation to T cells in drain-
ing lymph nodes where specific immune responses are
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162initiated (Schon-Hegrad et al., 1991). DC from humans
can be grown in vitro from a number of sources (i.e., cord
blood, skin), and Langerhans cells, mature circulating
blood DC, and immature DC from blood monocytes have
been reported as permissive to and productively infected
by MV Edmonston, MV Halle, or wt MV (Bhardwaj, 1997;
Fugier-Vivier et al., 1997; Grosjean et al., 1997; Kaiserlian
et al., 1997; Schnorr et al., 1997). However, little or no
such evidence exists in vivo. DC express both CD46 and
SLAM. With in vitro infection, two events are seen. Early
on, cocultures of MV-infected DCs and T cells interfere
with DC and T cell function associated with IL-12 pro-
duction and CD40 signaling. Later, by day 3 to 4, DC
integrity and viability become markedly compromised,
with death by apoptosis approaching levels of 40 to 70%.
Poor antigen presentation by DC, enhanced MV produc-
tion (up to 18-fold, by activated T cells), and increased
syncytial formation results in death of 90% of cells, pre-
sumably mediated by the TNF-rec superfamily.
Past assessment of the CNS during uncomplicated
MV infection revealed lymphocyte infiltration into the
cerebral spinal fluids and abnormal electroencephalo-
grams (Gibbs et al., 1959; Katz, 1995). Study of autopsy
material from those dying of diseases other than viral
infection have found MV antigens or nucleic acid se-
quences (Haase et al., 1981; Katayama et al., 1995) in the
CNS. Further, chronic and persistent MV infection in-
volves primarily the CNS (Griffin, 2001; Katz, 1985) with
the neuron most often infected.
Hence, the understanding of MV tropism, spread, and
pathogenesis requires the identification of a common
receptor or alternatively several distinct receptors or
coreceptor molecules involving cells of the nasal–respi-
ratory tract, lymphoid cells, and CNS. Recent studies
with other DNA or RNA viruses have most often pointed
to usage of several receptors as opposed to a single
universal receptor (reviewed in Baranowski et al., 2001;
Fields Virology, 2001).
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leagues (2002), evidence is presented primarily for in-
volvement of SLAM with mention of CD46 and a non-
SLAM non-CD46 receptor for MV. This appears, at this
time, to be the most reasonable assessment of MV
receptor usage. With a series of elegant studies, Yanagi
first associated SLAM as a receptor for MV (Tatsuo et al.,
2000) and his minireview (Yanagi et al., 2002) traces that
work and its implications. Subsequent work by Hsu et al.
(2001) confirmed Yanagi’s observation and showed
SLAM as a receptor for lymphotropic strains of MV. Our
studies of SLAM or CD46-receptor expression on the
clinical target cells of MV have failed, under conditions
used, to detect SLAM on nasal–epithelial cells of human
subjects or on cultured neurons, although CD46 mole-
cules were detected with ease (Table 1). Interestingly,
analysis of a variety of cell markers on the 1 to 3% of
SLAM-positive cells in nasal scrapes showed no coseg-
regation of SLAM with V5, a marker for normal epi-
thelia or dendritic cells; with CD14, a marker for macro-
phages; or with conventional markers for intraepithelial
human T cells. This suggests that a previously unknown
and to be defined cell in the nasal mucosa bears SLAM.
The weight of evidence currently on hand suggests
that multiple (different) receptors are likely to be involved
in MV spread and pathogenesis. Future investigation of
acute MV infection and identification of the receptor on
the cell infected by MV should be illuminating. Similarly
and concurrently, the several laboratories making and
utilizing human SLAM expressing transgenic mice alone
and crossed to CD46 receptor bearing transgenic mice
may well provide information on the use of these recep-
tors in the spread of MV infection.
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TABLE 1
Differential Expression of MV Receptor Molecules SLAM and CD46
on Target Cells
Cells
Expression of
SLAM CD46
B95-8 marmoset  (100%) nil (0%)
Neurons
Line TMR-2 nil (0%)  (100%)
Line CHR-16 nil (0%)  (100%)
Fetal nil (0%)  (80%)
Nasal epithelial cellsa  (0.5–3%)  (98%)
Lymphocyte  (10–24%)b
CD4 and CD8  (100%)c  (100%)b
a Nasal scrapes were obtained on 10 individuals by Dr. D. Stevenson
(Scripps Clinic), separated in single-cell suspension with trypsin/EDTA,
washed in buffer containing sera, and double-sorted using monoclonal
antibody (mAb) to integrin labeled with Alexa 488 to identify epithelial
cells and with mAbs to either SLAM or CD46 conjugated to Cy5 and
then analyzed by FACS.
b Nonexperimentally activated PBL.
c Upon experimental activation.
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